Product image of Yttriumcitrat (90y) Curium Germany (Yttrium (90y) Citrate) supplied by GNH India

Yttriumcitrat (90y) Curium Germany

Active Ingredient:
Yttrium (90y) Citrate
Origin:
EU

Yttriumcitrat (90y) Curium Germany (Yttrium (90y) Citrate)

Yttrium (90Y) Citrate is a radiopharmaceutical used for intraarticular therapy. This sterile, non-pyrogenic solution is indicated for synovectomy in select patients. Always handled by healthcare professionals due to its radioactive properties.

Manufacturer / TM Owner

Cis Bio Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Yttrium (90Y) Citrate is primarily used for radiation synovectomy in patients with chronic synovitis, particularly in joints unresponsive to conventional therapies. It delivers localized radiation to reduce inflammation and pain in affected joints. This treatment is typically reserved for cases where systemic medications have proven ineffective.

Side Effects

  • Following intraarticular administration, Yttrium (90Y) Citrate emits beta radiation that targets inflamed synovial tissue. Patients may experience gradual reduction in joint swelling and discomfort over several weeks. The effects are localized to the injection site, minimizing systemic impact.

Precautions & Warnings

  • Yttrium (90Y) Citrate must be administered by trained medical professionals in a controlled setting. Protective measures, including shielding and proper disposal protocols, are essential due to its radioactive nature. Pregnant individuals and those breastfeeding should avoid exposure to this medication.

Avoid Interactions

  • As a radiopharmaceutical, Yttrium (90Y) Citrate does not interact with other medications in the traditional sense. However, concurrent use of other radioactive treatments or external beam radiation should be avoided to prevent overlapping exposure. Always inform healthcare providers about all medications and treatments being used.

Frequently Asked Questions

It is used for radiation synovectomy in patients with chronic joint inflammation, particularly when other treatments have not been effective.

It is administered via intraarticular injection directly into the affected joint by a healthcare professional.

No, it should not be used during pregnancy due to potential risks to the fetus from radiation exposure.

Common effects may include localized pain, swelling, or temporary worsening of joint symptoms post-injection.

It does not interact with medications in the traditional sense, but concurrent radiation therapies should be avoided.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Yttrium (90y) Citrate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT